US Oncology Pressing CMS For CAP Revisions, Though Not Submitting Bid
This article was originally published in The Pink Sheet Daily
Executive Summary
Delay in implementing the competitive acquisition program for Part B could lead to beneficial changes, the cancer services network states.
You may also be interested in...
ASP Reimbursement Drags Down US Oncology’s Adjusted Income
US Oncology is raising its adjusted net income guidance for 2005, despite sustaining an unforeseen 2% drop in its average sales price during the second quarter, compared with the year-ago period
CMS Halts Bidding For Competitive Drug Purchase Program, Pushes Start To July 2006
The Medicare agency says it needs more time to review public comments and make “clarifications” to its interim final rule for the Part B competitive acquisition program.
Part D Enrollment Deadline Approaches With Fewer Than 6 Mil. Eligibles Still Unenrolled
The federal government is on the verge of ensuring that 90% of Medicare-eligible people receive prescription drug coverage, HHS Secretary Leavitt said.